# Medications for Stopping Cocaine Dependence and Preventing Relapse

> **NCT00218023** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 101 (actual)

## Conditions studied

- Cocaine Abuse
- Cocaine-Related Disorders

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Levodopa/Carbidopa
- **DRUG:** Naltrexone HCl
- **DRUG:** Placebo
- **BEHAVIORAL:** Motivational Interviewing (MI)
- **BEHAVIORAL:** Contingency management (CM)
- **BEHAVIORAL:** Cognitive-Behavioral Therapy (CBT)

## Key facts

- **NCT ID:** NCT00218023
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2017-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218023, "Medications for Stopping Cocaine Dependence and Preventing Relapse". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00218023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*